<DOC>
	<DOCNO>NCT02221401</DOCNO>
	<brief_summary>Study demonstrate bioequivalence 2.5 mg linagliptin/1000 mg metformin fixed-dose combination ( FDC ) tablet compare single tablet linagliptin 2.5 mg metformin 1000 mg administer together .</brief_summary>
	<brief_title>Bioequivalence Linagliptin / Metformin Fixed-dose Combination ( FDC ) Tablet Compared With Single Linagliptin Metformin Tablets Administered Together Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>1 . Healthy men woman accord follow criterion : base upon complete medical history , include physical examination , vital sign ( Blood pressure ( BP ) , Pulse Rate ( PR ) ) , 12lead ECG , clinical laboratory test 2 . Age 18 55 year ( inclusive ) 3 . Body mass index ( BMI ) 18.5 29.9 kg/m2 ( inclusive ) 4 . Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 4 . Surgery gastrointestinal tract ( except appendectomy ) 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 6 . History relevant orthostatic hypotension , faint spell blackouts 7 . Chronic relevant acute infection 8 . History relevant allergy hypersensitivity ( include allergy drug excipients ) 9 . Intake drug within 1 month less 10 halflives respective drug prior first study drug administration 10 . Participation another trial investigational drug within 2 month prior administration trial 11 . Smoker ( 10 cigarette 3 cigar 3 pipe daily ) 12 . Alcohol abuse ( average consumption 20 g/day woman 30 g/day men ) 13 . Drug abuse 14 . Blood donation ( 100 mL within 4 week Day 1 Visit 2 ) 15 . Any laboratory value outside reference range clinical relevance 16 . Inability comply dietary regimen trial site For female subject childbearing potential : 17 . Positive pregnancy test , pregnancy plan become pregnant study within 2 month study completion 18 . No adequate contraception study 1 month study completion , e.g . follow : implant , injectables , combine hormonal contraceptive , hormonal intrauterine device , sexual abstinence least 1 month prior first study drug administration , vasectomise partner ( vasectomy perform least 1 year prior enrolment ) , surgical sterilization ( include hysterectomy ) . Women vasectomise partner , sexually abstinent surgically sterile ask use additional barrier method ( e.g . condom ) . 19 . Lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>